The advanced research and development facilities and new peptide developments by the pharmaceutical companies are propelling the demand for cost effective peptide therapeutics. However, production of peptides in a large scale with the increasing complexities of peptides is a major challenge for the global peptide therapeutics market. Development of multifunctional peptides and increasing number of collaboration for the development of peptide conjugates are trends in the global peptide therapeutics market.
Request for report sample at: https://www.psmarketresearch.com/market-analysis/peptide-therapeutics-market/report-sample
Peptide therapeutics market can be categorized on the basis of marketing type, route of administration, application, and. Based on marketing type, the peptide therapeutics market can be categorized as generic peptides and branded peptides. On the basis of route of administration, peptide therapeutics market can be segmented as oral mode of administration and parenteral mode of administration.
In addition, based on applications, the market can be categorized as gastrointestinal disorders, infection, respiratory disorders, central nervous system, metabolic disorders, cardiovascular diseases, hematological disorders, acromegaly, cancer and others. Cancer leads the market due to increasing number of new cancer cases.
Asia-Pacific is the fastest growing region in the global peptide therapeutics market. The major reasons for the fastest growth in the region are growing research and development activities, increasing prevalence of cancer and cardiovascular diseases, and increasing healthcare expenditure. Moreover, the peptide therapeutics market is growing rapidly due to the high generic drug market potential in the emerging economies, such as India and China.
Some of the major players operating in the global peptide therapeutics market are, Sanofi, Teva Pharmaceutical Industries Ltd., Novartis AG, Ipsen S.A., AstraZeneca plc, Amgen Inc., Eli Lilly and Company, Lonza Group Ltd., Merck & Co. Inc., Novo Nordisk A/S, F. Hoffmann-La Roche AG, Bachem Holding AG, PolyPeptide Group, and CordenPharma International GmbH.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]